Heart failure and dilated cardiomyopathy develop in mice that lack the musc
le LIM protein (MLP) gene (MLP-/-). The character and extent of the heart f
ailure that occurs in MLP-/- mice were investigated using echocardiography
and in vivo pressure-volume (P-V) loop measurements. P-V loop data were obt
ained with a new method for mice (sonomicrometry) using two pairs of orthog
onal piezoelectric crystals implanted in the endocardial wall. Sonomicromet
ry revealed right-shifted P-V loops in MLP-/- mice, depressed systolic cont
ractility, and additional evidence of heart failure. Cellular changes in ML
P-/- mice were examined in isolated single cells using patch-clamp and conf
ocal Ca2+ concentration ([Ca2+]) imaging techniques. This cellular investig
ation revealed unchanged Ca2+ currents and Ca2+ spark characteristics but d
ecreased intracellular [Ca2+] transients and contractile responses and a de
fect in excitation-contraction coupling. Normal cellular and whole heart fu
nction was restored in MLP-/- mice that express a cardiac-targeted transgen
e, which blocks the function of beta -adrenergic receptor (beta -AR) kinase
-1 (beta ARK1). These data suggest that, despite the persistent stimulus to
develop heart failure in MLP-/- mice (i.e., loss of the structural protein
MLP), downregulation and desensitization of the beta -ARs may play a pivot
al role in the pathogenesis. Furthermore, this work suggests that the inhib
ition of bARK1 action may prove an effective therapy for heart failure.